Volume 28, Issue 3 (Avicenna Journal of Clinical Medicine-Autumn 2021)
Avicenna J Clin Med 2021, 28(3): 186-193 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Fallah M, Mosayebi M, Matini M, Darabi F. Prevalence of Trichomoniasis and Determination of in Vitro Susceptibility of Isolated Parasites to Metronidazole in Women Referred to Health Centers in Arak, Iran, in 2020. Avicenna J Clin Med 2021; 28 (3) :186-193
URL: http://sjh.umsha.ac.ir/article-1-2306-en.html
URL: http://sjh.umsha.ac.ir/article-1-2306-en.html
1- Professor, Department of Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences , fallah@umsha.ac.ir
2- Associate Professor, Department of Parasitology and Mycology, School of Medicine, Arak University of Medical Sciences
3- Associate Professor, Department of Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences
4- MSc Student in Parasitology, Department of Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences
2- Associate Professor, Department of Parasitology and Mycology, School of Medicine, Arak University of Medical Sciences
3- Associate Professor, Department of Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences
4- MSc Student in Parasitology, Department of Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences
Abstract: (1490 Views)
Background and Objective: Trichomoniasis is the most common sexually transmitted parasitic disease in the world. Due to its importance and the need for recognizing its prevalence and epidemiology, this study was conducted to determine the rate of T. vaginalis infection in women referred to Health Centers in Arak, Iran, in 2020.
Materials and Methods: In this cross-sectional study, from 630 women undergoing genital examinations, a sample of the vaginal swab was prepared, kept in a special container, and transferred to the laboratory
within 2 hours. Furthermore, a questionnaire containing demographic characteristics and clinical signs of patients was completed. The samples were examined using two methods of wet smear and culture in a Diamond medium. The obtained data were recorded and analyzed.
Results: According to the results, 41.5% of the participants were in the age group of 25 to 34 years. The prevalence of trichomoniasis in the study population was 0.9%. The rate of infection was not related to age and education level; however, it was related to the marital status of patients (P<0.003). The most common symptom in patients was vaginal discharge, which was present in 67.1% of the women. Infection of patients showed statistically significant differences with different intensities of vaginal discharge, consistency of vaginal discharge, as well as itching and burning. The minimum lethal dose of metronidazole was determined to be 6.2 μg/ml in 24 hours and 1.6 μg/ml in 48 hours.
Conclusion: The prevalence of trichomoniasis in this population was relatively low and was associated with marital status, clinical symptoms, discharge and consistency of vaginal discharge, as well as burning and itching. Moreover, the investigated samples were sensitive to metronidazole.
Materials and Methods: In this cross-sectional study, from 630 women undergoing genital examinations, a sample of the vaginal swab was prepared, kept in a special container, and transferred to the laboratory
within 2 hours. Furthermore, a questionnaire containing demographic characteristics and clinical signs of patients was completed. The samples were examined using two methods of wet smear and culture in a Diamond medium. The obtained data were recorded and analyzed.
Results: According to the results, 41.5% of the participants were in the age group of 25 to 34 years. The prevalence of trichomoniasis in the study population was 0.9%. The rate of infection was not related to age and education level; however, it was related to the marital status of patients (P<0.003). The most common symptom in patients was vaginal discharge, which was present in 67.1% of the women. Infection of patients showed statistically significant differences with different intensities of vaginal discharge, consistency of vaginal discharge, as well as itching and burning. The minimum lethal dose of metronidazole was determined to be 6.2 μg/ml in 24 hours and 1.6 μg/ml in 48 hours.
Conclusion: The prevalence of trichomoniasis in this population was relatively low and was associated with marital status, clinical symptoms, discharge and consistency of vaginal discharge, as well as burning and itching. Moreover, the investigated samples were sensitive to metronidazole.
Type of Study: Original |
Subject:
Parasitology & Mycology
Extended Abstract [HTML 22 KB] (71 Download)
References
1. Polat ZA, Cetin A, Savage PB. Evaluation of the in vitro activity of ceragenins against Trichomonas vaginalis. Acta Parasitol. 2016;61(2):376-81. [DOI] [PubMed]
2. Orozco E, Marchat LA, Gómez C, López-Camarillo C, Pérez DG. Drug resistance mechanisms in Entamoeba histolytica, Giardia lamblia, Trichomonas vaginalis, and opportunistic anaerobic protozoa. Antimicrobial drug resistance: Springer; 2009. p. 549-59. [DOI]
3. Karimi FZ, Bakhshi M, Dadgar S, Maleki-Saghooni N. Review of anti-Trichomonas vaginalis herbs and their therapeutic effects. Iran. J. Obstet. Gynecol. Infertil. 2018;20(12):96-109.
4. Küng E, Fürnkranz U, Walochnik J. Chemotherapeutic options for the treatment of human trichomoniasis. Int J Antimicrob Agents. 2019;53(2):116-27. [DOI] [PubMed]
5. Ali V, Nozaki T. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by “amitochondriate” protozoan parasites. Clin Microbiol Rev. 2007;20(1):164-87. [DOI] [PubMed]
6. Joesoef M, Schmid G, Hillier S. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis. 1999;28(Supplement_1):S57-S65. [DOI] [PubMed]
7. Anthwal A, Rajesh UC, Rawat M, Kushwaha B, Maikhuri JP, Sharma VL, et al. Novel metronidazole–chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis. Eur J Med Chem. 2014;79:89-94. [DOI] [PubMed]
8. Hawkins I, Carne C, Sonnex C, Carmichael A. Successful treatment of refractory Trichomonas vaginalis infection using intravenous metronidazole. Int J STD AIDS. 2015;26(9):676-8. [DOI] [PubMed]
9. Gülmezoglu AM, Garner P. Trichomoniasis treatment in women: a systematic review. Trop Med Int Health. 1998;3(7): 553-58. [DOI] [PubMed]
10. McGREGOR JA, ISMAIL M, McCORMACK WM. A Pilot Study of Metronidazole Vaginal Gel Versus Oral Metronidazole for the Treatment ofTrichomonas vaginalisVaginitis. Sex Transm Dis. 1998;25(3):176-9. [DOI] [PubMed]
11. Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med. 2001;46(6):545-9. [PubMed]
12. Narcisi E, Secor W. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob Agents Chemother. 1996;40(5):1121-5. [DOI] [PubMed]
13. Organization WH. Global incidence and prevalence of selected curable sexually transmitted infections-2008: World Health Organization; 2012.
14. Shuter J, Bell D, Graham D, Holbrook KA, Bellin EY. Rates of and risk factors for trichomoniasis among pregnant inmates in New York City. Sex Transm Dis. 1998;25(6):303-7. [DOI] [PubMed]
15. Magnus M, Clark R, Myers L, Farley T, Kissinger PJ. Trichomonas vaginalis among HIV-Infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity? Sex Transm Dis. 2003;30(11):839-43. [DOI] [PubMed]
16. Johnston VJ, Mabey DC. Global epidemiology and control of Trichomonas vaginalis. Curr Opin Infect Dis. 2008;21(1):56-64. [DOI] [PubMed]
17. Ginocchio C, Chapin K, Smith J, Aslanzadeh J, Snook J, Hill C, et al. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol. 2012;50(8):2601-8. [DOI] [PubMed]
18. Matini M, Rezaei H, Fallah M, Maghsood AH, Saidijam M, Shamsi-Ehsan T. Genotyping, drug susceptibility and prevalence survey of Trichomonas vaginalis among women attending gynecology clinics in Hamadan, western Iran, in 2014–2015. Iran J Parasitol. 2017;12(1):29-37. [PubMed]
19. Akbari.Z MM. Evaluation of Trichomonas vaginalis infection in pregnant women referred to the laboratory of Hamadan Health Center in 2015. 1394.
20. Arbabi M, Fakhrieh Z, Delavari M, Abdoli A. Prevalence of Trichomonas vaginalis infection in Kashan city, Iran (2012-2013). Iran J Reprod Med. 2014;12(7):507-512. [PubMed]
21. Matini M, Rezaie S, Mohebali M, Maghsood A, Rabiee S, Fallah M, et al. Prevalence of Trichomonas vaginalis Infection in Hamadan City, Western Iran. Iran J Parasitol. 2012;7(2):67-72. [PubMed]
22. Bakhtiari A, HAJIAN TK, Pasha H. Genital infection by Trichomonas Vaginalis in women referring to Babol health centers: prevalence and risk factors. 2008. Iran Red Crescent Med J. 2008;10(1):16-21
23. Akbari Z, Matini M. The study of trichomoniasis in pregnantwomen attending hamadan city health centers in 2015. Avicenna. J. Clin. Microb. Infec. 2017;4(2):41533. [DOI]
24. Baghchesaraie H, Salmani R, Amini B. Prevalence of Trichomonas Vaginalis Infection Among Women Refered to Laboratories in Zanjan, 2010. J Res Dev Nurs Midwifery. 2012;9(1):69-75.
25. Etminan Rad S, Bokaii M. Investigation of Trichomoniasis infection in women referred to clinic of gynaecology and hygienic centers of Yazd, 2006. Sci J Health. 2007;2:14-20.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Hamadan University of Medical Sciences
Published by UMSHA Press
Journal Tel: +988138380924
Publisher Tel:+988138380548
Website: http://sjh.umsha.ac.ir
Email: s_ journal[at]umsha.ac.ir
